Jane Street
ASND icon

Jane Street’s Ascendis Pharma A/S ASND Stock Holding History

Jane Street’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.2M Sell
66,400
-7,200
-10% -$1.61M ﹤0.01% 2049
2025
Q4 		$15.7M Hold
73,600
– – ﹤0.01% 1827
2025
Q3 		$14.6M Buy
73,600
+45,200
+159% +$8.43M ﹤0.01% 1965
2025
Q2 		$4.9M Buy
28,400
+5,800
+26% +$945K ﹤0.01% 3019
2025
Q1 		$3.52M Buy
22,600
+20,000
+769% +$2.86M ﹤0.01% 3469
2024
Q4 		$358K Sell
2,600
-10,200
-80% -$1.34M ﹤0.01% 7437
2024
Q3 		$1.91M Buy
12,800
+8,300
+184% +$1.12M ﹤0.01% 4572
2024
Q2 		$614K Sell
4,500
-200
-4% -$27.2K ﹤0.01% 6684
2024
Q1 		$710K Buy
4,700
+2,000
+74% +$285K ﹤0.01% 6057
2023
Q4 		$340K Sell
2,700
-22,100
-89% -$2.2M ﹤0.01% 7427
2023
Q3 		$2.32M Sell
24,800
-17,100
-41% -$1.6M ﹤0.01% 3803
2023
Q2 		$3.74M Buy
41,900
+1,200
+3% +$104K ﹤0.01% 3158
2023
Q1 		$4.36M Sell
40,700
-125,500
-76% -$14.4M ﹤0.01% 2639
2022
Q4 		$20.3M Buy
166,200
+6,300
+4% +$731K 0.01% 998
2022
Q3 		$16.5M Buy
159,900
+95,200
+147% +$9.03M 0.01% 1239
2022
Q2 		$6.01M Sell
64,700
-20,800
-24% -$1.96M ﹤0.01% 2391
2022
Q1 		$10M Buy
85,500
+79,300
+1,279% +$9.18M ﹤0.01% 1984
2021
Q4 		$834K Sell
6,200
-12,900
-68% -$1.92M ﹤0.01% 6271
2021
Q3 		$3.04M Buy
19,100
+11,800
+162% +$1.61M ﹤0.01% 3622
2021
Q2 		$960K Buy
7,300
+1,200
+20% +$160K ﹤0.01% 5926
2021
Q1 		$786K Sell
6,100
-14,900
-71% -$2.26M ﹤0.01% 5931
2020
Q4 		$3.5M Buy
21,000
+13,900
+196% +$2.3M ﹤0.01% 2594
2020
Q3 		$1.1M Sell
7,100
-5,300
-43% -$762K ﹤0.01% 3946
2020
Q2 		$1.83M Buy
+12,400
New +$1.7M ﹤0.01% 3185

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jane Street's ASND Position: Q1 2026 in Review

Jane Street sold out of Ascendis Pharma A/S (ASND) in Q1 2026, closing a stake of 21,225 shares — an estimated $4.76M sold.

Jane Street first reported a position in ASND in Q3 2017 and held it in 23 quarters. The position peaked at $7.53M in Q1 2025. 273 funds tracked by Wall St. Rank hold ASND as of Q1 2026.

  • Jane Street reported no remaining Ascendis Pharma A/S position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 21,225 Ascendis Pharma A/S shares in Q1 2026, an estimated $4.76M.
  • Jane Street first reported a position in Ascendis Pharma A/S in Q3 2017 and held it in 23 quarters.
  • Jane Street's Ascendis Pharma A/S position peaked at $7.53M in Q1 2025.
  • 273 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.